| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/28/2009 | CN100455302C Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 01/28/2009 | CN100455300C Compound wild kiwi tablet and its preparing method |
| 01/28/2009 | CN100455297C Quality detecting method for Radix-Acanthopanacis-leaf total flavone extract frozen dry powder injecta |
| 01/28/2009 | CN100455296C Medication for treating dysmenorhea |
| 01/28/2009 | CN100455295C Dripping pill made from red rice and its preparing method |
| 01/28/2009 | CN100455294C Process for preparing chick embryo element |
| 01/28/2009 | CN100455291C Notoginseng medicine composition for treating cardiac and cerebral vascular diseases |
| 01/28/2009 | CN100455289C Anticancer compositions comprising methenamine |
| 01/28/2009 | CN100455288C Formula of Reynoldazine hydrochloride prepn. |
| 01/28/2009 | CN100455287C Formulations |
| 01/28/2009 | CN100455286C Injection of palonosetron and preparation process thereof |
| 01/28/2009 | CN100455285C Albendazole new form for treating adenoid hypertrophy |
| 01/28/2009 | CN100455282C Process for producing medicine |
| 01/28/2009 | CN100455281C Yinhuang lozenge dripping pill preparation and its preparing method |
| 01/28/2009 | CN100455280C An externally applied ointment |
| 01/28/2009 | CN100455279C Oral administered sustained release lozenge composition and its preparation method |
| 01/28/2009 | CN100455278C Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
| 01/27/2009 | US7482383 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract |
| 01/27/2009 | US7482381 For use in actuating or drug delivery devices containing an artificial muscle valve and micropump that controls the release of therapeutic fluids including implantable platforms |
| 01/27/2009 | US7482377 Administering an immediate release oral dosage of diclofenac or in salt form together with one or more alkali metal bicarbonates in an amount of >20% by weight; palatable and free from any unpleasant taste or side effects; short time to the maximum plasma concentration; high maximum plasma concentration |
| 01/27/2009 | US7482031 Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482022 Palatable chewable tablet |
| 01/27/2009 | US7482020 for making an adjuvanted vaccine comprising host albumin. The process comprises mixing host serum or host serum with an antigen, and then mixing the resulting mixture with an adjuvant. |
| 01/27/2009 | US7482019 Preparing chitosan-calcium complexes via degrading chitosan in acidic solution, alkalizing mixture, vigorously agitate, precipitate and recover complex; medicines; pharmeceuticals |
| 01/27/2009 | US7482018 Using hydrophilic surfactant; encapsulated hydrophobic drug |
| 01/27/2009 | US7481996 Aerosol cosmetic composition |
| 01/27/2009 | US7481995 Aerosol composition |
| 01/27/2009 | US7481788 Medical device for delivering patches |
| 01/27/2009 | CA2595096A1 Herbal product comprising cinnamon and chocolate |
| 01/27/2009 | CA2523989C Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use |
| 01/27/2009 | CA2489407C Lasofoxifene tablet and its coating |
| 01/27/2009 | CA2476653C Cross-linked bioactive hydrogel matrices |
| 01/27/2009 | CA2474701C Preparation of biodegradeable microparticles containing a biologically active agent |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/27/2009 | CA2399856C Antibiotic composition with inhibitor |
| 01/27/2009 | CA2395226C Devices for the delivery of drugs having antiprogestinic properties |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2378385C Patch formulation for external use including an acid addition salt of a basic drug |
| 01/27/2009 | CA2362499C Combinations of formoterol and mometasone furoate for asthma |
| 01/27/2009 | CA2360248C Combinations of formoterol and a tiotropium salt |
| 01/27/2009 | CA2354034C Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/27/2009 | CA2350894C Methods for preparing coated drug particles and pharmaceutical formulations thereof |
| 01/27/2009 | CA2348451C Dosage forms containing taste masked active agents |
| 01/27/2009 | CA2342866C Stent coating |
| 01/27/2009 | CA2332038C Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 01/27/2009 | CA2319736C Water purification apparatus |
| 01/27/2009 | CA2294586C Homoserine lactones biofilm regulating compounds and their methods of use |
| 01/27/2009 | CA2265198C Method of producing a nicotine medicament and a medicament made by the method |
| 01/27/2009 | CA2264028C A stable ointment containing acetyl salicylic acid |
| 01/22/2009 | WO2009012449A1 Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
| 01/22/2009 | WO2009012443A1 Nanoparticles for the elution of growth factors for recovery and regeneration of organs |
| 01/22/2009 | WO2009012303A2 Therapeutic stable nanoparticles |
| 01/22/2009 | WO2009012121A1 A composition method for the prevention and relief of the symptoms of an incompetent or patulous eustachian tube |
| 01/22/2009 | WO2009012075A1 Use of iop-lowering agents for treating primary and secondary forms of glaucoma |
| 01/22/2009 | WO2009011967A1 Oral pharmaceutical dosage form and manufacturing method thereof |
| 01/22/2009 | WO2009011883A1 Compositions and methods for wound healing |
| 01/22/2009 | WO2009011705A1 Enhanced formulations of lamotrigine |
| 01/22/2009 | WO2009011658A1 Hollow porous microspheres |
| 01/22/2009 | WO2009011584A2 A method of preparing a pharmaceutical co-crystal composition |
| 01/22/2009 | WO2009011451A1 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/22/2009 | WO2009011449A2 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 01/22/2009 | WO2009011367A1 Aqueous composition |
| 01/22/2009 | WO2009011112A1 Stable fat emulsion containing prostaglandin e1 |
| 01/22/2009 | WO2009010986A1 Topical cream compositions of sertaconazole nitrate |
| 01/22/2009 | WO2009010967A1 An agent for treatment of inflammation |
| 01/22/2009 | WO2009010842A2 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| 01/22/2009 | WO2009010837A2 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer |
| 01/22/2009 | WO2009010770A2 Dry-powder medicament |
| 01/22/2009 | WO2009010719A1 Method for cell manipulation |
| 01/22/2009 | WO2009010494A2 Micro-particles, blood-substitute and method for forming same |
| 01/22/2009 | WO2009010303A2 System for administering active substances to an organism, devices for use in said type of system and method for producing said type of devices |
| 01/22/2009 | WO2009010238A2 Duloxetine formulations |
| 01/22/2009 | WO2009010071A1 Osteopontin nanoparticles system for drug delivery |
| 01/22/2009 | WO2009009953A1 A composition of orally gargle tablet and preparative method |
| 01/22/2009 | WO2008143906A3 Hypercompressed particles for controlled release of ophthalmic medications |
| 01/22/2009 | WO2008143705A3 Methods and compositions for rapid inactivation of proteins |
| 01/22/2009 | WO2008139078A3 Gaseous mixture containing o2 and n2o for preventing or reducing hyperalgesia |
| 01/22/2009 | WO2008135460A3 Aqueous aerosol preparations containing therapeutically active micro-organisms or parts of micro-organisms and method for producing corresponding aerosols |
| 01/22/2009 | WO2008091870A3 Pharmaceutical compositions comprising atorvastatin and nicotinic acid |
| 01/22/2009 | WO2008063766A3 Amorphous ezetimibe and the production thereof |
| 01/22/2009 | WO2008040534A3 Non-mucoadhesive film dosage forms |
| 01/22/2009 | US20090024210 Medication depot for medical implants |
| 01/22/2009 | US20090024114 Method and system for control of osmotic pump device |
| 01/22/2009 | US20090024113 Multi-reservoir medical device having protected interior walls |
| 01/22/2009 | US20090024112 Medical injector with compliance tracking and monitoring |
| 01/22/2009 | US20090024074 Electrochemically degradable polymers |
| 01/22/2009 | US20090023766 Pharmaceutical formulation of apomorphine for buccal administration |
| 01/22/2009 | US20090023690 Oral drug delivery system |
| 01/22/2009 | US20090023689 Oral drug delivery system |
| 01/22/2009 | US20090023644 Methods of using cgrp for cardiovascular and renal indications |
| 01/22/2009 | US20090022809 Stable taste masked formulations of cephalosporins |
| 01/22/2009 | US20090022808 Coated Hyaluronic Acid Particles |
| 01/22/2009 | US20090022807 Drug formulations having inert sealed cores |
| 01/22/2009 | US20090022806 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof |
| 01/22/2009 | US20090022805 Polypeptide microparticles having sustained release characteristics, methods and uses |
| 01/22/2009 | US20090022804 Chemoembolisation |
| 01/22/2009 | US20090022803 Oral Formulations For Delivery of Catecholic Butanes Including Ndga Compounds |